The target Hb level for patients with CKD without dialysis and those undergoing PD is between 11 g/dL to 13 g/dL, according to the guidelines of the Japanese Society for Dialysis Therapy [9]. This evidence concerns the gene GSTM1 and chronic kidney disease.